Rapport Therapeutics

Series-B+
rapportrx.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Series-B+
Last Announced Aug 23, 2023
Investors Undisclosed
Decision Makers 6 Verified

About Rapport Therapeutics

Precision medicines to match the complexity of the human brain.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website rapportrx.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Series-B+ announced

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Rapport Therapeutics.

Funding History

1 Round
Series-B+ · Aug 23, 2023

Founders & Leadership

1

David Bredt

Founder, Chief Scientific Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts